Cigna Group stock holds steady as analysts lift targets
Published on 09/14/2026 at 19:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Cigna Group stock (ISIN US1255231003) most recently closed at USD 280.51 on the New York Stock Exchange on September 11, 2026, keeping the managed-care giant in a market-capitalization range of about USD 74.18 billion based on data reported on September 12, 2026.
Analyst consensus supports valuation
According to MarketBeat on September 14, 2026, Cigna Group carries a consensus rating of Moderate Buy from 23 analysts, with a consensus price target of USD 337.10, indicating upside potential of roughly 20 percent versus the recent closing level around USD 280.
In the same overview, Evercore is cited with an In-line rating and a price target of USD 290.00 for Cigna Group as of September 9, 2026, positioning its target about USD 9.49 above the September 11, 2026 close of USD 280.51 and roughly 3.4 percent higher than that latest reference price.
Fresh targets and rating changes in detail
As MarketBeat reports, Raymond James cut its rating on Cigna Group from Strong Buy to Outperform and reduced its price target from USD 350.00 to USD 320.00 in a research note dated August 3, 2026, trimming the target by USD 30.00 but still projecting a level about USD 39.49 above the September 11, 2026 closing price.
Jefferies Financial Group downgraded Cigna Group from Buy to Hold and lowered its price objective from USD 336.00 to USD 307.00 on August 4, 2026, according to MarketBeat, which places the revised target USD 26.49 above the latest closing level of USD 280.51.
In addition, Wells Fargo raised its price objective on the stock from USD 305.00 to USD 307.00 on July 31, 2026, maintaining an Equal Weight rating per MarketBeat, a modest USD 2.00 increase that still implies around 9.4 percent upside from USD 280.51.
Fundamental backdrop and recent earnings
A snapshot of Cigna Group’s fundamentals compiled by Pluang on September 14, 2026, highlights a trailing price-earnings ratio of about 11.61, situating the stock toward the lower end of valuation ranges for large US health insurers and suggesting that the shares may be priced conservatively relative to their earnings power.
The same overview notes that in the second quarter of 2026 Cigna Group delivered earnings per share of USD 7.78, beating the consensus estimate of USD 7.60 by USD 0.18 or about 2.4 percent, reinforcing the picture of steady execution and incremental outperformance versus analyst expectations.
Dividend investors received a further data point on September 8, 2026, when The Cigna Group shares traded ex-dividend for a quarterly cash payout of USD 1.56 per share, payable on September 23, 2026, according to Stock Analysis, which puts the annualized dividend at USD 6.24 per share if maintained.
Market capitalization and trading context
Per Nasdaq figures summarized by CompaniesMarketCap, The Cigna Group’s market capitalization stood at USD 74.18 billion as of September 12, 2026, placing it around rank 336 globally by equity value and underscoring its role as a major player in the health services and managed-care segment.
Recent trading data show Cigna Group stock changing hands around the USD 280 mark on September 11, 2026, with a closing level of USD 280.51 that remained within the day’s reported range and left the shares modestly below their recent highs, giving investors a reference level that sits well within the 52-week span highlighted by market data providers.
Closing price perspective
With Cigna Group stock most recently closing at USD 280.51 on the NYSE on September 11, 2026, and the company’s market capitalization reported at USD 74.18 billion as of September 12, 2026, the shares currently trade at a level that is supported by earnings beats and a Moderate Buy analyst consensus while still sitting below average price targets around USD 337.
Key data on Cigna Group stock
- Company: The Cigna Group Inc.
- ISIN: US1255231003
- Ticker: CI
- Trading venue: NYSE
- Price (as of September 11, 2026): 280.51 USD
- Market capitalization: 74.18 billion USD (as of September 12, 2026)
- Sector / Industry: Health care / Managed care and health services
- Index membership: S&P 500
